Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | EP300 | Q09472 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.35 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7064563 | 0.99 | EP300 (0.41) | LMNAEP300MAPTALDH1A1NPC1 | |
| SCHEMBL1224879 | 0.86 | EP300 (0.46) | LMNAEP300ALDH1A1GAAKDM4E | |
| SCHEMBL12883796 | 0.86 | EP300 (0.36) | EP300 | |
| SCHEMBL12883799 | 0.84 | EP300 (0.39) | EP300MAPTALDH1A1RAB9AGAA | |
| SCHEMBL7062249 | 0.77 | ALB (0.35) | EP300NPC1 | |
| SCHEMBL12883815 | 0.77 | LMNA (0.35) | LMNAMAPTALDH1A1RAB9AKDM4E | |
| SCHEMBL1224033 | 0.77 | ASAH1 (0.57) | LMNAASAH1CYP3A4 | |
| SCHEMBL12883801 | 0.76 | ALB (0.34) | EP300 | |
| SCHEMBL2221563 | 0.75 | ALB (0.39) | LMNAEP300ALDH1A1L3MBTL1GAA | |
| SCHEMBL1224980 | 0.75 | TSHR (0.38) | LMNAALDH1A1RAB9AL3MBTL1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103897004-B | Synthesis method of capecitabine | 鲁南制药集团股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-103897004-A | Synthesis method of capecitabine | LUNAN PHARM GROUP CORP | 2014-07-02 | — | — | CN | claimed |
| CN-102241721-A | Method for preparing capecitabine and hydroxyl derivative intermediate thereof | UNIV JIANGNAN | 2011-11-16 | — | — | CN | claimed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | claimed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | claimed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | claimed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | claimed |
| CN-111377988-B | Capecitabine intermediate | 鲁南制药集团股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-111100172-B | Cytosidine derivative and method for preparing capecitabine medicine from same | 中国科学院昆明植物研究所 | 2023-03-17 | — | — | CN | disclosed |
| CN-111377981-B | 5-deoxy-D-ribose derivative | 鲁南制药集团股份有限公司 | 2023-03-17 | — | — | CN | disclosed |
| WO-2020140559-A1 | 5-DEOXY-D-RIBOSE DERIVATIVE | 山东新时代药业有限公司 | 2020-07-09 | — | — | WO | disclosed |
| CN-111377981-A | 5-deoxy-D-ribose derivative | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111377988-A | Capecitabine intermediate | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | disclosed |
| WO-2010065586-A2 | PREPARATION OF CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-06-10 | — | — | WO | disclosed |
| WO-2010061402-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF CAPECITABINE | KANNAN VISHWANATH (IN) | 2010-06-03 | — | — | WO | disclosed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | disclosed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DPYD, TYMP, TYMS | LMNA 2171/4885EP300 4205/4885MAPT 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.